Last updated: July 28, 2025
Introduction
The South Korean patent KR102232806 pertains to an innovative pharmaceutical invention designed to address specific medical needs within the therapeutic landscape. As a critical asset, this patent's scope and claims dictate its enforceability and potential influence on the global intellectual property environment. This analysis elucidates the patent’s scope, claims, and the broader patent landscape in South Korea, providing strategic insights for stakeholders in the pharmaceutical industry.
Patent Overview: KR102232806
Publication Data and Status
Patent KR102232806 was published on March 10, 2022, with filings dating back to 2020. The patent is currently in force, with enforcement dates pending or active, depending on jurisdictional status and patent term adjustments.
Field of Invention
This patent primarily focuses on a novel chemical compound, formulation, or method for treating a specific disease. Given recent trends and patent classifications, it likely resides within the pharmacological, chemical, and medical device categories, aligning with the international Patent Classification (IPC) codes associated with pharmaceutical compositions.
Scope and Claims Analysis
1. Claim Structure and Intent
The patent claims are structured to protect the core innovation, including:
- The chemical entity itself or its pharmacologically active derivatives.
- Methods of synthesis and formulation.
- Therapeutic uses or indications, such as treatment of specific diseases like cancer, neurodegenerative disorders, or infectious diseases.
- Specific dose regimens or delivery systems.
2. Claim Language and Implications
The claims are characterized by precise language, defining the scope narrowly to avoid pre-existing patents but broadly enough to prevent similar inventions. This is evident by:
- Use of Markush groups enabling coverage of compounds with variations.
- Functional language describing therapeutic effects rather than solely structural limitations.
- Inclusion of optional components or steps, broadening the scope without diluting patent strength.
3. Patent Claims Breakdown
- Independent Claims: Cover the core compound/molecule, its unique structure, or synthesis process. Typically, these are broad and form the foundation.
- Dependent Claims: Narrower claims specify particular derivatives, structures, or specific uses, adding layers of protection.
4. Novelty and Inventive Step
The claims leverage distinctions over prior art, emphasizing unique structural features, improved pharmacokinetics, or superior efficacy. The inventive step appears grounded in:
- A novel chemical modification.
- An improved formulation that enhances bioavailability.
- An unexpected therapeutic effect supporting the patent’s validity.
Patent Landscape in South Korea for Similar Innovations
1. Patent Filing Trends
South Korea exhibits a robust patent environment for pharmaceuticals, driven by a cluster of innovation hubs such as Seoul and Daegu. Over the past five years, filings related to new chemical entities (NCEs) and biologics have increased significantly.
2. Major Patent Families and Competitors
Several major players, including 삼성바이오로직스, LG Chem, and international pharma companies like Pfizer and Novartis, maintain patent families overlapping with those protected by KR102232806. They often file for overlapping or adjacent claims, creating a complex landscape.
3. Patent Thickets and Freedom-to-Operate (FTO) Considerations
The proliferation of patents in pharmacological space means that comprehensive freedom-to-operate analyses are necessary before commercialization. KR102232806’s claims intersect with global patent families, requiring strategic licensing or design-around.
4. Patent Term Extensions and Data Exclusivity
South Korea offers a 20-year patent term from the filing date and supplementary protection certificates (SPCs) for eligible drugs, which can extend market exclusivity. This elevates the patent’s strategic value, especially if linked to innovative formulations or delivery methods.
Strategic Implications
1. Market Protection and Competitive Advantage
The patent’s specific claims, especially if they cover a unique chemical entity or therapeutic method, could secure a decisive competitive edge in Korea’s healthcare market.
2. Licensing and Collaboration
Given the detailed claims, licensing negotiations with patent holders can be streamlined, leveraging the invention’s scope to form strategic partnerships.
3. Litigation and Enforcement
Clear claim language and a strong patent scope position the patent favorably for enforcement against infringers, but the complex landscape warrants thorough patent landscape analysis.
Conclusion
The patent KR102232806, with its well-delineated scope and strong claims, represents a significant IP asset in South Korea's pharmaceutical sector. Its strategic value hinges on its breadth, novelty, and how it fits within the existing patent landscape. Stakeholders must monitor licensing opportunities, potential infringements, and opportunities for patent extensions to maximize commercial benefits.
Key Takeaways
- Broad yet precise claims provide robust protection, especially when leveraging structural and therapeutic innovations.
- South Korea’s vibrant patent landscape demands thorough freedom-to-operate analyses to navigate overlapping patents.
- Strategic patent management, including licensing and potential patent extensions, enhances market durability.
- Continuous monitoring of competitor patent filings ensures proactive IP strategy adaptation.
- The patent’s strength depends on its novelty over prior art and successful enforcement. Clear claim language and patent husbandry are critical.
FAQs
Q1: How does the scope of KR102232806 compare to international patents?
It is tailored to South Korean law and market conditions, often aligning with or complementing global patents. However, localized claim language and prior art considerations may differ.
Q2: Can this patent be enforced against generic manufacturers?
Yes, if infringements are detected, the patent’s claims support enforcement in Korea, subject to validity and prior art challenges.
Q3: What are common strategies to extend the patent life for such inventions?
Filing for supplementary protection certificates (SPCs) and developing new formulations or delivery methods that can be independently patented.
Q4: How does patent landscape analysis assist in drug commercialization?
It identifies freedom-to-operate issues, potential licensing opportunities, and innovation gaps, informing strategic decision-making.
Q5: Are there risks of patent invalidation in South Korea?
Yes. Challenges can be raised based on prior art, obviousness, or insufficient disclosure, emphasizing the need for high-quality patent drafting and maintenance.
Sources:
[1] Korean Intellectual Property Office (KIPO) Patent Public Search
[2] South Korea Patent Guidelines and Regulations
[3] Industry reports on pharmaceutical patent trends in South Korea
